Table 1.1 Top Prescribed Drugs by Total Expenditures, 2014
Total
expenditures
ranking |
Prescribed drug
(generic name) |
Trade name(s)
sold under |
Total
expenditures |
Total number
of persons with
expenditures |
| 1 |
Insulin Glargine |
Lantus
Toujeo |
8,567,803,456 |
3,594,337 |
| 2 |
Rosuvastatin |
Crestor |
7,703,435,696 |
4,341,817 |
| 3 |
Esomeprazole |
Nexium |
6,448,397,445 |
3,287,592 |
| 4 |
Aripiprazole |
Abilify |
6,412,868,895 |
1,040,073 |
| 5 |
Insulin Aspart |
Novolog |
6,294,745,984 |
1,695,103 |
| 6 |
Etanercept |
Enbrel |
6,267,372,961 |
## |
| 7 |
Adalimumab |
Humira |
6,109,088,246* |
## |
| 8 |
Fluticasone-Salmeterol |
Advair |
5,576,859,578 |
3,466,437 |
| 9 |
Atorvastatin |
Lipitor |
5,360,273,851 |
14,845,378 |
| 10 |
Pregabalin |
Lyrica |
4,142,106,022 |
1,798,331 |
| 11 |
Tiotropium |
Spiriva |
4,085,356,392 |
2,035,236 |
| 12 |
Insulin Isophane (Nph) |
Humulin N
Novolin N |
3,971,439,017 |
4,771,655 |
| 13 |
Duloxetine |
Cymbalta
Irenka |
3,381,235,294 |
2,569,369 |
| 14 |
Budesonide-Formoterol |
Symbicort |
3,238,639,507 |
2,425,335 |
| 15 |
Omeprazole |
First-Omeprazole
Prilosec |
3,185,374,252 |
13,779,592 |
| 16 |
Sitagliptin |
Januvia |
3,024,657,388 |
1,381,437 |
| 17 |
Gabapentin |
Fanatrex
Gralise
Horizant
Neurontin |
2,939,319,536 |
7,577,082 |
| 18 |
Ezetimibe |
Zetia |
2,837,633,003 |
1,619,923 |
| 19 |
Albuterol |
Accuneb
Proair
Proventil
Ventolin
Vospire ER |
2,833,839,203 |
15,442,510 |
| 20 |
Insulin Lispro |
Humalog |
2,641,875,614 |
1,103,986 |
| 21 |
Methylphenidate |
Aptensio XR
Concerta
Daytrana
Metadate
Methylin
Quillivant
Ritalin |
2,384,627,017 |
2,414,314 |
| 22 |
Amphetamine-Dextroamphetamine |
Adderall |
2,364,582,367 |
2,790,642 |
| 23 |
Quetiapine |
Seroquel |
2,363,269,786 |
1,669,934 |
| 24 |
Mesalamine |
Apriso
Asacol
Canasa
Delzicol
Lialda
Pentasa
Rowasa |
2,353,037,419* |
## |
| 25 |
Celecoxib |
Celebrex |
2,151,699,245 |
1,722,332 |
Standard Errors for Table 1.1: Top Prescribed Drugs
by Total Expenditures, 2014
Prescribed drug
(generic name) |
Total
expenditures |
Total number
of persons with
expenditures |
| Insulin Glargine |
912,377,501 |
256,321 |
| Rosuvastatin |
673,437,737 |
326,835 |
| Esomeprazole |
656,380,453 |
279,222 |
| Aripiprazole |
825,934,054 |
115,768 |
| Insulin Aspart |
1,282,478,114 |
185,186 |
| Etanercept |
1,503,058,093 |
## |
| Adalimumab |
1,876,751,270* |
## |
| Fluticasone-Salmeterol |
493,188,462 |
252,690 |
| Atorvastatin |
423,629,688 |
620,763 |
| Pregabalin |
711,500,269 |
207,178 |
| Tiotropium |
613,241,619 |
239,125 |
| Insulin Isophane (Nph) |
376,259,001 |
290,588 |
| Duloxetine |
378,937,913 |
234,182 |
| Budesonide-Formoterol |
361,608,957 |
276,422 |
| Omeprazole |
282,035,081 |
637,301 |
| Sitagliptin |
354,371,350 |
150,320 |
| Gabapentin |
367,084,747 |
409,339 |
| Ezetimibe |
356,938,484 |
178,097 |
| Albuterol |
189,294,795 |
623,558 |
| Insulin Lispro |
415,497,426 |
135,596 |
| Methylphenidate |
308,475,693 |
215,347 |
| Amphetamine-Dextroamphetamine |
387,300,129 |
281,589 |
| Quetiapine |
506,442,159 |
166,159 |
| Mesalamine |
1,028,641,737* |
## |
| Celecoxib |
345,186,584 |
176,288 |
## Less than 100 sample persons.
* Relative standard error equal to or greater than 30%.
Return To Top
|
Back
Email Updates
